Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'WIN-35,428' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 101 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Barrett, T; Xie, T; Piao, Y; Dillon-Carter, O; Kargul, GJ; Lim, MK; Chrest, FJ; Wersto, R; Rowley, DL; Juhaszova, M; Zhou, L; Vawter, MP; Becker, KG; Cheadle, C; Wood, WH; McCann, UD; Freed, WJ; Ko, MS; Ricaurte, GA; Donovan, DM
      A murine dopamine neuron-specific cDNA library and microarray: Increased COXI expression during methamphetamine neurotoxicity

      NEUROBIOLOGY OF DISEASE
    2. Laakso, A; Bergman, J; Haaparanta, M; Vilkman, H; Solin, O; Syvalahti, E; Hietala, J
      Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia

      SCHIZOPHRENIA RESEARCH
    3. Rinne, JO; Nurmi, E; Ruottinen, HM; Bergman, J; Eskola, O; Solin, O
      [F-18]FDOPA and [F-18]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease

      SYNAPSE
    4. Fischman, AJ; Bonab, AA; Babich, JW; Livni, E; Alpert, NM; Meltzer, PC; Madras, BK
      [C-11,I-127] altropane: A highly selective ligand for PET imaging of dopamine transporter sites

      SYNAPSE
    5. Cho, AK; Melega, WP; Kuczenski, R; Segal, DS
      Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse

      SYNAPSE
    6. Letchworth, SR; Nader, MA; Smith, HR; Friedman, DP; Porrino, LJ
      Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys

      JOURNAL OF NEUROSCIENCE
    7. Deng, XL; Wang, Y; Chou, J; Cadet, JL
      Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method

      MOLECULAR BRAIN RESEARCH
    8. Corera, AT; Do-Rego, JC; Costentin, J; Bonnet, JJ
      Differential sensitivity to NaCl for inhibitors and substrates that recognize mutually exclusive binding sites on the neuronal transporter of dopamine in rat striatal membranes

      NEUROSCIENCE RESEARCH
    9. Yuan, J; Callahan, BT; McCann, UD; Ricaurte, GA
      Evidence against an essential role of endogenous brain dopamine in methamphetamine-induced dopaminergic neurotoxicity

      JOURNAL OF NEUROCHEMISTRY
    10. Reith, MEA; Berfield, JL; Wang, LC; Ferrer, JV; Javitch, JA
      The uptake inhibitors cocaine and benztropine differentially alter the conformation of the human dopamine transporter

      JOURNAL OF BIOLOGICAL CHEMISTRY
    11. Sabol, KE; Roach, JT; Broom, SL; Ferreira, C; Preau, MM
      Long-term effects of a high-dose methamphetamine regimen on subsequent methamphetamine-induced dopamine release in vivo

      BRAIN RESEARCH
    12. Ouchi, Y; Kanno, T; Okada, H; Yoshikawa, E; Futatsubashi, M; Nobezawa, S; Torizuka, T; Tanaka, K
      Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson's disease

      BRAIN
    13. Sekine, Y; Iyo, M; Ouchi, Y; Matsunaga, T; Tsukada, H; Okada, H; Yoshikawa, E; Futatsubashi, M; Takei, N; Mori, N
      Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET

      AMERICAN JOURNAL OF PSYCHIATRY
    14. Volkow, ND; Chang, L; Wang, GJ; Fowler, JS; Leonido-Yee, M; Franceschi, D; Sedler, MJ; Gatley, SJ; Hitzemann, R; Ding, YS; Logan, J; Wong, C; Miller, EN
      Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers

      AMERICAN JOURNAL OF PSYCHIATRY
    15. Isovich, E; Mijnster, MJ; Flugge, G; Fuchs, E
      Chronic psychosocial stress reduces the density of dopamine transporters

      EUROPEAN JOURNAL OF NEUROSCIENCE
    16. McCann, UD; Ricaurte, GA
      Drug abuse and dependence: hazards and consequences of heroin, cocaine andamphetamines

      CURRENT OPINION IN PSYCHIATRY
    17. Bobes, J; McCann, UD
      Developments in the treatment of drug dependence

      CURRENT OPINION IN PSYCHIATRY
    18. Melega, WP; Lacan, G; Desalles, AAF; Phelps, ME
      Long-term methamphetamine-induced decreases of [C-11]WIN 35,428 binding instriatum are reduced by GDNF: PET studies in the vervet monkey

      SYNAPSE
    19. Nurmi, E; Ruottinen, HM; Kaasinen, V; Bergman, J; Haaparanta, M; Solin, O; Rinne, JO
      Progression in Parkinson's disease: A positron emission tomography study with a dopamine transporter ligand [F-18] CFT

      ANNALS OF NEUROLOGY
    20. Nurmi, E; Bergman, J; Eskola, O; Solin, O; Hinkka, SM; Sonninen, P; Rinne, JO
      Reproducibility and effect of levodopa on dopamine transporter function measurements: A [F-18]CFT PET study

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    21. Xie, T; McCann, UD; Kim, S; Yuan, J; Ricaurte, GA
      Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: Implications for methamphetamine-induced dopaminergic neurotoxicity

      JOURNAL OF NEUROSCIENCE
    22. Kimmel, HL; Carroll, FI; Kuhar, MJ
      Dopamine transporter synthesis and degradation rate in rat striatum and nucleus accumbens using RTI-76

      NEUROPHARMACOLOGY
    23. Corera, AT; Costentin, J; Bonnet, JJ
      Binding of uptake blockers to the neuronal dopamine transporter: further investigation about cationic and anionic requirements

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    24. Wang, LJC; Berfield, JL; Kuhar, MJ; Carroll, FI; Reith, MEA
      RTI-76, an isothiocyanate derivative of a phenyltropane cocaine analog, asa tool for irreversibly inactivating dopamine transporter function in vitro

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    25. Ladenheim, B; Krasnova, IN; Deng, XL; Oyler, JM; Polettini, A; Moran, TH; Huestis, MA; Cadet, JL
      Methamphetamine-induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6

      MOLECULAR PHARMACOLOGY
    26. Hogan, KA; Staal, RGW; Sonsalla, PK
      Analysis of VMAT2 binding after methamphetamine or MPTP treatment: Disparity between homogenates and vesicle preparations

      JOURNAL OF NEUROCHEMISTRY
    27. Li, LB; Reith, MEA
      Interaction of Na+, K+, and Cl- with the binding of amphetamine, octopamine, and tyramine to the human dopamine transporter

      JOURNAL OF NEUROCHEMISTRY
    28. Chen, NH; Ferrer, JV; Javitch, JA; Justice, JB
      Transport-dependent accessibility of a cytoplasmic loop cysteine in the human dopamine transporter

      JOURNAL OF BIOLOGICAL CHEMISTRY
    29. Kim, GM; Kim, SE; Lee, WY
      Preclinical impairment of the striatal dopamine transporter system in sporadic olivopontocerebellar atrophy: Studied with [I-123]beta-CIT and SPECT

      EUROPEAN NEUROLOGY
    30. Harvey, DC; Lacan, G; Tanious, SP; Melega, WP
      Recovery from methamphetamine induced long-term nigrostriatal dopaminergicdeficits without substantia nigra cell loss

      BRAIN RESEARCH
    31. Schenk, S; Partridge, B; Shippenberg, TS
      Reinstatement of extinguished drug-taking behavior in rats: effect of the kappa-opioid receptor agonist, U69593

      PSYCHOPHARMACOLOGY
    32. Katz, JL; Izenwasser, S; Terry, P
      Relationships among dopamine transporter affinities and cocaine-like discriminative-stimulus effects

      PSYCHOPHARMACOLOGY
    33. Kuhlmann, AC; Guilarte, TR
      Regional and temporal expression of the peripheral benzodiazepine receptorin MPTP neurotoxicity

      TOXICOLOGICAL SCIENCES
    34. Cumming, P; Yokoi, F; Chen, AJ; Deep, P; Dagher, A; Reutens, D; Kapczinski, F; Wong, DF; Gjedde, A
      Pharmacokinetics of radiotracers in human plasma during positron emission tomography

      SYNAPSE
    35. Ouchi, Y; Yoshikawa, E; Okada, H; Futatsubashi, M; Sekine, Y; Iyo, M; Sakamoto, M
      Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: Compartment analysis for beta-CFT binding with positron emission tomography

      ANNALS OF NEUROLOGY
    36. Nobrega, JN; Gernert, M; Loscher, W; Raymond, R; Belej, T; Richter, A
      Tyrosine hydroxylase immunoreactivity and [H-3]win 35,428 binding to the dopamine transporter in a hamster model of idiopathic paroxysmal dystonia

      NEUROSCIENCE
    37. Vaugeois, JM; Corera, AT; Deslandes, A; Costentin, J
      Although chemically related to amineptine, the antidepressant tianeptine is not a dopamine uptake inhibitor

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    38. Ilgin, N; Zubieta, J; Reich, SG; Dannals, RF; Ravert, HT; Frost, JJ
      PET imaging of the dopamine transporter in progressive supranuclear palsy and Parkinson's disease

      NEUROLOGY
    39. Rinne, JO; Ruottinen, H; Bergman, J; Haaparanta, M; Sonninen, P; Solin, O
      Usefulness of a dopamine transporter PET ligand [F-18]beta-CFT in assessing disability in Parkinson's disease

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    40. Li, LB; Reith, MEA
      Modeling of the interaction of Na+ and K+ with the binding of dopamine and[H-3]WIN 35,428 to the human dopamine transporter

      JOURNAL OF NEUROCHEMISTRY
    41. MATTES CE; BELENDIUK GW; LYNCH TJ; BRADY RO; DRETCHEN KL
      BUTYRYLCHOLINESTERASE - AN ENZYME ANTIDOTE FOR COCAINE INTOXICATION

      Addiction biology
    42. MADRAS BK; MELTZER PC; LIANG AY; ELMALEH DR; BABICH J; FISCHMAN AJ
      ALTROPANE, A SPECT OR PET IMAGING PROBE FOR DOPAMINE NEURONS - I - DOPAMINE TRANSPORTER BINDING IN PRIMATE BRAIN

      Synapse
    43. MADRAS BK; GRACZ LM; MELTZER PC; LIANG AY; ELMALEH DR; KAUFMAN MJ; FISCHMAN AJ
      ALTROPANE, A SPECT OR PET IMAGING PROBE FOR DOPAMINE NEURONS - II - DISTRIBUTION TO DOPAMINE-RICH REGIONS OF PRIMATE BRAIN

      Synapse
    44. MADRAS BK; GRACZ LM; FAHEY MA; ELMALEH D; MELTZER PC; LIANG AY; STOPA EG; BABICH J; FISCHMAN AJ
      ALTROPANE, A SPECT OR PET IMAGING PROBE FOR DOPAMINE NEURONS - III - HUMAN DOPAMINE TRANSPORTER IN POSTMORTEM NORMAL AND PARKINSONS DISEASED BRAIN

      Synapse
    45. FISCHMAN AJ; BONAB AA; BABICH JW; PALMER EP; ALPERT NM; ELMALEH DR; CALLAHAN RJ; BARROW SA; GRAHAM W; MELTZER PC; HANSON RN; MADRAS BK
      RAPID DETECTION OF PARKINSONS-DISEASE BY SPECT WITH ALTROPANE - A SELECTIVE LIGAND FOR DOPAMINE TRANSPORTERS

      Synapse
    46. LAAKSO A; BERGMAN J; HAAPARANTA M; VILKMAN H; SOLIN O; HIETALA J
      [F-18] CFT ([F-18]WIN-35,428), A RADIOLIGAND TO STUDY THE DOPAMINE TRANSPORTER WITH PET - CHARACTERIZATION IN HUMAN-SUBJECTS

      Synapse
    47. BROWNELL AL; LIVNI E; GALPERN W; ISACSON O
      IN-VIVO PET IMAGING IN RAT OF DOPAMINE TERMINALS REVEALS FUNCTIONAL NEURAL TRANSPLANTS

      Annals of neurology
    48. Melega, WP; Lacan, G; Harvey, DC; Huang, SC; Phelps, ME
      Dizocilpine and reduced body temperature do not prevent methamphetamine-induced neurotoxicity in the vervet monkey: [C-11]WIN 35,428 positron emission tomography studies

      NEUROSCIENCE LETTERS
    49. MCCANN UD; WONG DF; YOKOI F; VILLEMAGNE V; DANNALS RF; RICAURTE GA
      REDUCED STRIATAL DOPAMINE TRANSPORTER DENSITY IN ABSTINENT METHAMPHETAMINE AND METHCATHINONE USERS - EVIDENCE FROM POSITRON-EMISSION-TOMOGRAPHY STUDIES WITH [C-11] WIN-35,428

      The Journal of neuroscience
    50. VILLEMAGNE V; YUAN J; WONG DF; DANNALS RF; HATZIDIMITRIOU G; MATHEWS WB; RAVERT HT; MUSACHIO J; MCCANN UD; RICAURTE GA
      BRAIN DOPAMINE NEUROTOXICITY IN BABOONS TREATED WITH DOSES OF METHAMPHETAMINE COMPARABLE TO THOSE RECREATIONALLY ABUSED BY HUMANS - EVIDENCE FROM [C-11] WIN-35,428 POSITRON-EMISSION-TOMOGRAPHY STUDIES AND DIRECT IN-VITRO DETERMINATIONS

      The Journal of neuroscience
    51. ZHANG L; ELMER LW; LITTLE KY
      EXPRESSION AND REGULATION OF THE HUMAN DOPAMINE TRANSPORTER IN A NEURONAL CELL-LINE

      Molecular brain research
    52. MALISON RT; MCCANCE E; CARPENTER LL; BALDWIN RM; SEIBYL JP; PRICE LH; KOSTEN TR; INNIS RB
      [I-123] BETA-CIT SPECT IMAGING OF DOPAMINE TRANSPORTER AVAILABILITY AFTER MAZINDOL ADMINISTRATION IN HUMAN COCAINE ADDICTS

      Psychopharmacology
    53. MILLER GW; STALEY JK; HEILMAN CJ; PEREZ JT; MASH DC; RYE DB; LEVEY AI
      IMMUNOCHEMICAL ANALYSIS OF DOPAMINE TRANSPORTER PROTEIN IN PARKINSONS-DISEASE

      Annals of neurology
    54. ALLARD P; NORLEN M
      UNCHANGED DENSITY OF CAUDATE-NUCLEUS DOPAMINE UPTAKE SITES IN DEPRESSED SUICIDE VICTIMS

      Journal of neural transmission
    55. COULTER CL; HAPPE HK; MURRIN LC
      DOPAMINE TRANSPORTER DEVELOPMENT IN POSTNATAL RAT STRIATUM, AN AUTORADIOGRAPHIC STUDY WITH [H-3]WIN 35,428

      Developmental brain research
    56. HUME SP; BROWN DJ; ASHWORTH S; HIRANI E; LUTHRA SK; LAMMERTSMA AA
      IN-VIVO SATURATION KINETICS OF 2 DOPAMINE TRANSPORTER PROBES MEASUREDUSING A SMALL ANIMAL POSITRON-EMISSION-TOMOGRAPHY SCANNER

      Journal of neuroscience methods
    57. CHEN NH; DING JH; WANG YL; REITH MEA
      POTENTIAL MISCONCEPTIONS IN DOPAMINE TRANSPORTER ASSAYS ARISING FROM THE BINDING OF [I-125] RTI-121 TO FILTERS - EFFECT OF IONS AND COCAINE

      Journal of neuroscience methods
    58. XU C; COFFEY LL; REITH MEA
      BINDING DOMAINS FOR BLOCKERS AND SUBSTRATES ON THE DOPAMINE TRANSPORTER IN RAT STRIATAL MEMBRANES STUDIED BY PROTECTION AGAINST N-ETHYLMALEIMIDE-INDUCED REDUCTION OF [H-3]WIN-35,428 BINDING

      Naunyn-Schmiedeberg's archives of pharmacology
    59. LI HK; GEORGE VK; CROSSLAND WJ; ANDERSON GF; DHABUWALA CB
      CHARACTERIZATION OF COCAINE BINDING-SITES IN THE RAT TESTES

      The Journal of urology
    60. WU Q; COFFEY LL; REITH MEA
      CATIONS AFFECT [H-3] MAZINDOL AND [H-3] WIN-35,428 BINDING TO THE HUMAN DOPAMINE TRANSPORTER IN A SIMILAR FASHION

      Journal of neurochemistry
    61. FREY K; KILBOURN M; ROBINSON T
      REDUCED STRIATAL VESICULAR MONOAMINE TRANSPORTERS AFTER NEUROTOXIC BUT NOT AFTER BEHAVIORALLY-SENSITIZING DOSES OF METHAMPHETAMINE

      European journal of pharmacology
    62. REITH MEA; XU C; CHEN NH
      PHARMACOLOGY AND REGULATION OF THE NEURONAL DOPAMINE TRANSPORTER

      European journal of pharmacology
    63. ZHANG L; COFFEY LL; REITH MEA
      REGULATION OF THE FUNCTIONAL-ACTIVITY OF THE HUMAN DOPAMINE TRANSPORTER BY PROTEIN-KINASE-C

      Biochemical pharmacology
    64. WILSON AA; DASILVA JN; HOULE S
      IN-VIVO EVALUATION OF [C-11] AND [F-18] LABELLED COCAINE ANALOGUES ASPOTENTIAL DOPAMINE TRANSPORTER LIGANDS FOR POSITRON EMISSION TOMOGRAPHY

      Nuclear medicine and biology
    65. HITRI A; LITTLE KY; ELLINWOOD EH
      EFFECT OF COCAINE ON DOPAMINE TRANSPORTER RECEPTORS DEPENDS ON ROUTESOF CHRONIC COCAINE ADMINISTRATION

      Neuropsychopharmacology
    66. MORRIS ED; BABICH JW; ALPERT NM; BONAB AA; LIVNI E; WEISE S; HSU HB; CHRISTIAN BT; MADRAS BK; FISCHMAN AJ
      QUANTIFICATION OF DOPAMINE TRANSPORTER DENSITY IN MONKEYS BY DYNAMIC PET IMAGING OF MULTIPLE INJECTIONS OF C-11 CFT

      Synapse
    67. HAAPARANTA M; BERGMAN J; LAAKSO A; HIETALA J; SOLIN O
      [F-18]CFT ([F-18]WIN-35,428), A RADIOLIGAND TO STUDY THE DOPAMINE TRANSPORTER WITH PET - BIODISTRIBUTION IN RATS

      Synapse
    68. MADRAS BK; JONES AG; MAHMOOD A; ZIMMERMAN RE; GARADA B; HOLMAN BL; DAVISON A; BLUNDELL P; MELTZER PC
      TECHNEPINE - A HIGH-AFFINITY (99M)TECHNETIUM PROBE TO LABEL THE DOPAMINE TRANSPORTER IN BRAIN BY SPECT IMAGING

      Synapse
    69. KOUTSILIERI E; KORNHUBER J; DEGEN HJ; LESCH KP; SOPPER S; TERMEULEN V; RIEDERER P
      U-373 MG GLIOBLASTOMA AND IMR-32 NEUROBLASTOMA CELL-LINES EXPRESS THEDOPAMINE AND VESICULAR MONOAMINE TRANSPORTERS

      Journal of neuroscience research
    70. MOODY CA; GRANNEMAN JG; BANNON MJ
      DOPAMINE TRANSPORTER BINDING IN RAT STRIATUM AND NUCLEUS-ACCUMBENS ISUNALTERED FOLLOWING CHRONIC CHANGES IN DOPAMINE LEVELS

      Neuroscience letters
    71. MULLER L; HALLDIN C; LUNDKVIST C; SWAHN CG; FOGED C; HALL H; KARLSSON P; GINOVART N; NAKASHIMA Y; SUHARA T; FARDE L
      DEVELOPMENT OF RADIOLIGANDS FOR THE DOPAMINE TRANSPORTER

      Journal of radioanalytical and nuclear chemistry
    72. BROWNELL AL; ELMALEH DR; MELTZER PC; SHOUP TM; BROWNELL GL; FISCHMAN AJ; MADRAS BK
      COCAINE CONGENERS AS PET IMAGING PROBES FOR DOPAMINE TERMINALS

      The Journal of nuclear medicine
    73. WILSON JM; LEVEY AI; RAJPUT A; ANG L; GUTTMAN M; SHANNAK K; NIZNIK HB; HORNYKIEWICZ O; PIFL C; KISH SJ
      DIFFERENTIAL CHANGES IN NEUROCHEMICAL MARKERS OF STRIATAL DOPAMINE NERVE-TERMINALS IN IDIOPATHIC PARKINSONS-DISEASE

      Neurology
    74. REITH MEA; XU C; ZHANG LA; COFFEY LL
      TRANSLOCATION OF DOPAMINE AND BINDING OF WIN-35,428 MEASURED UNDER IDENTICAL CONDITIONS IN CELLS EXPRESSING THE CLONED HUMAN DOPAMINE TRANSPORTER

      Naunyn-Schmiedeberg's archives of pharmacology
    75. WONG DF; HARRIS JC; NAIDU S; YOKOI F; MARENCO S; DANNALS RF; RAVERT HT; YASTER M; EVANS A; ROUSSET O; BRYAN RN; GJEDDE A; KUHAR MJ; BREESE GR
      DOPAMINE TRANSPORTERS ARE MARKEDLY REDUCED IN LESCH-NYHAN DISEASE IN-VIVO

      Proceedings of the National Academy of Sciences of the United Statesof America
    76. LEE FJS; PRISTUPA ZB; CILIAX BJ; LEVEY AI; NIZNIK HB
      THE DOPAMINE TRANSPORTER CARBOXYL-TERMINAL TAIL - TRUNCATIONS SUBSTITUTION MUTANTS SELECTIVELY CONFER HIGH-AFFINITY DOPAMINE UPTAKE WHILE ATTENUATING RECOGNITION OF THE LIGAND-BINDING DOMAIN/

      The Journal of biological chemistry
    77. ZHANG L; REITH MEA
      REGULATION OF THE FUNCTIONAL-ACTIVITY OF THE HUMAN DOPAMINE TRANSPORTER BY THE ARACHIDONIC-ACID PATHWAY

      European journal of pharmacology
    78. ALLARD P; MARCUSSON JO; ROSS SB
      [H-3] WIN 35,428 BINDING IN THE HUMAN BRAIN

      Brain research
    79. REITH MEA; XU C; COFFEY LL
      BINDING DOMAINS FOR BLOCKERS AND SUBSTRATES ON THE CLONED HUMAN DOPAMINE TRANSPORTER STUDIED BY PROTECTION AGAINST N-ETHYLMALEIMIDE-INDUCEDREDUCTION OF A-CARBOMETHOXY-3-BETA-(4-FLUOROPHENYL)[H-3]TROPANE ([H-3]WIN-35,428) BINDING

      Biochemical pharmacology
    80. CHEN NH; XU C; COFFEY LL; REITH MEA
      -BETA-CARBOMETHOXY-3-BETA-(4-FLUOROPHENYL)TROPANE] BINDING TO RAT-BRAIN MEMBRANES - COMPARING DOPAMINE CELL BODY AREAS WITH NERVE-TERMINAL REGIONS

      Biochemical pharmacology
    81. DESAINTHILAIRE Z; PYTHON A; BLANC G; CHARNAY Y; GAILLARD JM
      EFFECTS OF WIN-35,428 A POTENT ANTAGONIST OF DOPAMINE TRANSPORTER ON SLEEP AND LOCOMOTOR-ACTIVITY IN RATS

      NeuroReport
    82. VALCHAR M; HANBAUER I
      RAT MESENCEPHALIC NEURONAL CELLS CULTURED FOR DIFFERENT PERIODS AS A MODEL OF DOPAMINE TRANSPORTER ONTOGENY

      Molecular neurobiology
    83. LAIHINEN AO; RINNE JO; NAGREN KA; LEHIKOINEN PK; OIKONEN VJ; RUOTSALAINEN UH; RUOTTINEN HM; RINNE UK
      PET STUDIES ON BRAIN MONOAMINE TRANSPORTERS WITH CARBON-11-BETA-CIT IN PARKINSONS-DISEASE

      The Journal of nuclear medicine
    84. ALOYO VJ; PAZDALSKI PS; KIRIFIDES AL; HARVEY JA
      BEHAVIORAL SENSITIZATION, BEHAVIORAL TOLERANCE, AND INCREASED [H-3]WIN-35,428 BINDING IN RABBIT CAUDATE-NUCLEUS AFTER REPEATED INJECTIONS OF COCAINE

      Pharmacology, biochemistry and behavior
    85. ROBINSON SE; MAHER JR; MCDOWELL KP; KUNKO PM
      EFFECTS OF COCAINE AND THE COCAINE ANALOG CFT ON GLUTAMATERGIC NEURONS

      Pharmacology, biochemistry and behavior
    86. TOLLIVER BK; CARNEY JM
      LOCOMOTOR STIMULANT EFFECTS OF COCAINE AND NOVEL COCAINE ANALOGS IN DBA 2J AND C57BL/6J INBRED MICE/

      Pharmacology, biochemistry and behavior
    87. GRACZ LM; MADRAS BK
      [H-3] WIN-35,428 ([H-3]CFT) BINDS TO MULTIPLE CHARGE-STATES OF THE SOLUBILIZED DOPAMINE TRANSPORTER IN PRIMATE STRIATUM

      The Journal of pharmacology and experimental therapeutics
    88. GATLEY SJ; DING YS; VOLKOW ND; CHEN RY; SUGANO Y; FOWLER JS
      BINDING OF D-THREO-[C-11]METHYLPHENIDATE TO THE DOPAMINE TRANSPORTER IN-VIVO - INSENSITIVITY TO SYNAPTIC DOPAMINE

      European journal of pharmacology
    89. COULTER CL; HAPPE HK; BERGMAN DA; MURRIN LC
      LOCALIZATION AND QUANTIFICATION OF THE DOPAMINE TRANSPORTER - COMPARISON OF [H-3]WIN-35,428 AND [I-125]RTI-55

      Brain research
    90. XU C; COFFEY LL; REITH MEA
      TRANSLOCATION OF DOPAMINE AND BINDING OF 2 BETA-CARBOMETHOXY-3 BETA-(4-FLUOROPHENYL) TROPANE (WIN-35,428) MEASURED UNDER IDENTICAL CONDITIONS IN RAT STRIATAL SYNAPTOSOMAL PREPARATIONS - INHIBITION BY VARIOUS BLOCKERS

      Biochemical pharmacology
    91. STATHIS M; SCHEFFEL U; LEVER SZ; BOJA JW; CARROLL FI; KUHAR MJ
      RATE OF BINDING OF VARIOUS INHIBITORS AT THE DOPAMINE TRANSPORTER IN-VIVO

      Psychopharmacology
    92. MADRAS BK; REITH MEA; MELTZER PC; DUTTA AK
      O-526, A PIPERIDINE ANALOG OF GBR-12909, RETAINS HIGH-AFFINITY FOR THE DOPAMINE TRANSPORTER IN MONKEY CAUDATE-PUTAMEN

      European journal of pharmacology. Molecular pharmacology section
    93. MADRAS BK; KAUFMAN MJ
      COCAINE ACCUMULATES IN DOPAMINE-RICH REGIONS OF PRIMATE BRAIN AFTER IV ADMINISTRATION - COMPARISON WITH MAZINDOL DISTRIBUTION

      Synapse
    94. WILSON AA; DASILVA JN; HOULE S
      FACILE RADIOLABELING AND PURIFICATION OF TA-[O-(CH3)-C-11]-CARBOMETHOXY-3-BETA-ARYLTROPANES - RADIOTRACERS FOR THE DOPAMINE TRANSPORTER

      Journal of labelled compounds & radiopharmaceuticals
    95. DING YS; SUGANO Y; FOWLER JS; SALATA C
      SYNTHESIS OF THE RACEMATE AND INDIVIDUAL ENANTIOMERS OF [C-11] METHYLPHENIDATE FOR STUDYING PRESYNAPTIC DOPAMINERGIC NEURON WITH POSITRON EMISSION TOMOGRAPHY

      Journal of labelled compounds & radiopharmaceuticals
    96. COFFEY LL; REITH MEA
      [H-3] WIN 35,428 BINDING TO THE DOPAMINE UPTAKE CARRIER .1. EFFECT OFTONICITY AND BUFFER COMPOSITION

      Journal of neuroscience methods
    97. REITH MEA; COFFEY LL
      [H-3] WIN 35,428 BINDING TO THE DOPAMINE UPTAKE CARRIER .2. EFFECT OFMEMBRANE FRACTIONATION PROCEDURE AND FREEZING

      Journal of neuroscience methods
    98. WILSON JM; NOBREGA JN; CORRIGALL WA; COEN KM; SHANNAK K; KISH SJ
      AMYGDALA DOPAMINE LEVELS ARE MARKEDLY ELEVATED AFTER SELF-ADMINISTRATION BUT NOT PASSIVE-ADMINISTRATION OF COCAINE

      Brain research
    99. WONG DF; YUNG B; DANNALS RF; SHAYA EK; RAVERT HT; CHEN CA; CHAN B; FOLIO T; SCHEFFEL U; RICAURTE GA; NEUMEYER JL; WAGNER HN; KUHAR MJ
      IN-VIVO IMAGING OF BABOON AND HUMAN DOPAMINE TRANSPORTERS BY POSITRONEMISSION TOMOGRAPHY USING [C-11] WIN-35,428

      Synapse
    100. REITH MEA; COFFEY LL
      CATIONIC AND ANIONIC REQUIREMENTS FOR THE BINDING OF TA-CARBOMETHOXY-3-BETA-(4-FLUOROPHENYL)[3H]TROPANE TO THE DOPAMINE UPTAKE CARRIER

      Journal of neurochemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/01/21 alle ore 22:12:13